| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |